Close Menu

Going for Broke

Biotechs are running out of cash, reports the Wall Street Journal. (OK, you probably already knew that.) In the past four months, 10 biotechs have gone bankrupt and, currently, 120 of the 360 publicly traded companies have less than six months' worth of cash -- the Journal's Health blog speculates that no one will be able to support the small biotechs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

An analysis of blood donations suggests SARS-CoV-2 was present in the US weeks earlier than thought, according to NPR.

The Guardian reports that DeepMind Technologies' AlphaFold can predict how proteins fold.

CNBC reports that a US Centers for Disease Control and Prevention advisory panel is to vote on how to distribute COVID-19 vaccines.

In PNAS this week: targeting progesterone signaling in ovarian cancer, LINE-1 retrotransposition events in adenocarcinomas, and more.